Compare RGEN & BSAC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | RGEN | BSAC |
|---|---|---|
| Founded | 1981 | 1977 |
| Country | United States | Chile |
| Employees | N/A | N/A |
| Industry | Medical/Dental Instruments | Commercial Banks |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 8.2B | 17.0B |
| IPO Year | N/A | 1994 |
| Metric | RGEN | BSAC |
|---|---|---|
| Price | $161.91 | $36.09 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 11 | 2 |
| Target Price | ★ $177.18 | $29.50 |
| AVG Volume (30 Days) | ★ 577.2K | 311.3K |
| Earning Date | 02-19-2026 | 01-30-2026 |
| Dividend Yield | N/A | ★ 2.74% |
| EPS Growth | N/A | ★ 22.83 |
| EPS | ★ 0.03 | 0.01 |
| Revenue | $707,890,000.00 | ★ $2,560,142,282.00 |
| Revenue This Year | $17.86 | $35.78 |
| Revenue Next Year | $12.44 | $6.84 |
| P/E Ratio | $5,257.58 | ★ $14.42 |
| Revenue Growth | ★ 11.74 | 10.15 |
| 52 Week Low | $102.97 | $19.66 |
| 52 Week High | $182.52 | $36.19 |
| Indicator | RGEN | BSAC |
|---|---|---|
| Relative Strength Index (RSI) | 45.60 | 75.88 |
| Support Level | $157.29 | $32.17 |
| Resistance Level | $174.87 | $33.34 |
| Average True Range (ATR) | 7.07 | 0.81 |
| MACD | -0.52 | 0.28 |
| Stochastic Oscillator | 23.05 | 98.65 |
Repligen, headquartered in Waltham, Massachusetts, is a global life sciences company that develops and sells bioprocessing equipment and supplies used in the manufacturing of biologic drugs, including monoclonal antibodies, recombinant proteins, vaccines, and cell and gene therapies. Its customers include biopharmaceutical companies, contract development and manufacturing organizations, or CDMOs, and other life science companies. It sells four main product categories: filtration (including fluid management) is the largest category and was 58% of 2024 revenue, while chromatography, proteins, and process analytics were 19%, 12%, and 9%, respectively. Customers in North America, Europe, and Asia Pacific contributed 44%, 37%, and 19% of revenue, respectively.
Founded in 1978, Banco Santander Chile is part of Santander Group and majority-controlled by Santander Spain. It is the largest bank in Chile by loans and the second largest by deposits. The bank generates most of its net interest income (roughly 65% of total revenue) from its mortgages, unsecured consumer credit lines, and commercial loans. Banco Santander's commercial loan business is more focused on small- to medium-size companies, with firms generating more than CLP 10,000 million in revenue only making up around 5% of outstanding loans. Outside of lending, Banco Santander is the largest card issuer in the country with around 25% of the market and benefits from a long-term strategic partnership with the largest airline in the country, LATAM.